Form 4: Myomo Inc. Chief Medical Officer Harry Kovelman Reports Stock Vesting

Harry Kovelman, Chief Medical Officer of Myomo, Inc., reports the vesting of performance-based restricted stock units.

Summary

• On June 9, 2024, Harry Kovelman, Chief Medical Officer of Myomo, Inc., reported the vesting of 1,235 shares of common stock.
• These shares resulted from performance-based restricted stock units granted under the company's 2018 Stock Option and Incentive Plan.
• The vesting was based on Myomo's relative stock price performance compared to a peer group from June 10, 2021, to March 9, 2024.
• Following the transaction, Kovelman directly owns 124,549 shares of Myomo common stock.
• The remaining 6,965 restricted stock units granted expired unvested.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock vesting, indicating that performance targets were partially met. The expiration of some units tempers any strong positive sentiment.

Positives

• The vesting of performance-based restricted stock units suggests that Myomo met certain performance criteria related to its stock price compared to its peers.

Negatives

• The expiration of 6,965 restricted stock units indicates that some performance targets were not met.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership. It provides transparency into the alignment of management's interests with those of shareholders through equity-based compensation.

Comparison to Industry Standards

• Stock-based compensation is a common practice in the technology and healthcare industries to incentivize executives and align their interests with shareholders.
• Vesting schedules and performance-based metrics vary widely across companies depending on their specific goals and compensation philosophies.
• Peer group comparisons are often used to determine the appropriateness of executive compensation packages.

Stakeholder Impact

• The vesting of stock options can have a minor dilutive effect on existing shareholders.
• The performance-based nature of the vesting aligns management's interests with shareholder value.

Key Dates